Metoprolol Succinate Tablet, Film Coated, Extended Release
Product Images NDC 72162-1859

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 72162-1859). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl721621859)

Each film-coated tablet contains 190 mg metoprolol succinate, USP equivalent to 200 mg of metoprolol tartrate, USP. It is important to keep this medication out of the reach of children. Store at 25°C with excursions permitted to 15-30°C. It is essential to verify the product before dispensing. For more information, refer to the Patient Package Inserts provided. The medication NDC code is 72162-1859-1. This Metoprolol Succinate Extended-Release Tablet is for prescription use only. Manufactured by Alkem Laboratories Ltd.*

FDA Label Image

Metoprolol-structure (Metoprolol Structure)

FDA Label Image

Metoprolol-table1a (Metoprolol Table1a)

This is a description of the results for subgroups in the MERIT-HF study related to total mortality, all-cause hospitalization, and heart failure events when comparing Metoprolol Succinate Extended-Release tablets with a placebo. The study includes data on various subgroups such as NYHA classification, ejection fraction, ischemic and non-ischemic etiology, sex, race, previous myocardial infarction, diabetes mellitus, hypertension, and heart rate. The information also includes the relative risk and 95% confidence intervals for the outcomes.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.